Market Size Estimation:
Both top-down and bottom-up approaches were used to estimate and validate the total size of the Cardiac Mapping Market. These methods were also used extensively to determine the extent of various subsegments in the market. The research methodology used to estimate the market size includes the following:
# The key players in the industry and markets have been identified through extensive secondary research
# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Expected Revenue Gains During Forecast Period:
The global cardiac mapping market size is expected to grow from USD 1.4 billion in 2019 to USD 2.1 billion by 2024, at a CAGR of 8.7% during the forecast period.
After arriving at the overall market size-using the market size estimation processes as explained above-the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the cardiac mapping industry.
Download PDF [email protected]
Major Growth Influencing Factors:
The inclusion of new entrants in the market, growing investments, funds, and grants, increasing incidence of target diseases, and growth in the geriatric population are the key drivers of the cardiac mapping systems market.
# In 2019, Acutuc medical partnered with Peerbridge Health, US. Under the partnership, Peerbridge Health offered its advanced ambulatory ECG—Peerbridge Cor that has been cleared to detect up to 26 different arrhythmias to be used with the AcQMap System.
# In 2018, Royal Philips acquired EPD Solutions, Israel, an innovator in image-guided procedures for cardiac arrhythmias.
Atrial fibrillation held the largest share of the cardiac mapping systems market in 2019
Cardiac mapping is used widely for the identification, characterization, and localization of an arrhythmia. The cardiac mapping systems indication market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), other arrhythmias. The atrial fibrillation segment held the largest share of the market in 2019, a trend that is expected to continue during the forecast period. The large share of this segment can primarily be attributed to the rising incidences of AF throughout the globe.
Key Questions Addressed by the Report:
# Which of the product segments will dominate the cardiac mapping market in the next five years?
# Emerging countries have immense opportunities for the growth and adoption of cardiac mapping. Will this scenario continue in the next five years?
# What are the upcoming technologies in the cardiac mapping market?
# Which indication segment will dominate the cardiac mapping market in the next five years?
# What will be the effect of the developments undertaken by market players?
The major players operating in the cardiac mapping market include Biosense Webster (US), Abbott (US), and Boston Scientific Corporation (US). The other players in this market include Medtronic (Ireland), MicroPort Scientific Corporation (China), EP Solutions SA (Switzerland), Acutus Medical (US), Koninklijke Philips N.V. (Royal Philips) (Netherlands), Lepu Medical (China), BIOTRONIK (Germany), AngioDynamics (US), BioSig Technologies (US), APN Health (US), CoreMap (US), Kardium (Canada), Catheter Precision (US), and Epmap-System (Germany).
Request Sample [email protected]